Gemcitabine or gemcitabine plus oxaliplatin in the first-line treatment of patients with advanced transitional cell carcinoma of the urothelium unfit for cisplatin-based chemotherapy: a randomized phase 2 study of the French Genitourinary Tumor Group (GETUG V01)
Nom du journal : Eur Urol
Année : 2011
Volume : 60
Page de départ : 1251
Page de fin : 1257